Dong-A Socio Holdings Co., Ltd. (KRX:000640)

Market Cap	613.83B -3.3%
Revenue (ttm)	1.43T +7.2%
Net Income	90.94B +56.7%
EPS	13,718.29 +56.8%
Shares Out	6.63M
PE Ratio	6.75
Forward PE	6.83
Dividend	1,679.61 (1.76%)
Ex-Dividend Date	Mar 11, 2026

Volume	7,540
Average Volume	16,941
Open	92,700
Previous Close	92,600
Day's Range	91,000 - 92,700
52-Week Range	91,400 - 121,845
Beta	0.12
RSI	38.16
Earnings Date	Apr 27, 2026

About Dong-A Socio Holdings

Dong-A Socio Holdings Co., Ltd. engages in the pharmaceutical business in South Korea and internationally. It offers Bacchus, Benachio, and Tempo; infection management products; imaging equipment, such as FX-V1 and CLS-S7 for surgery and diagnosis; and MEDIFLIX, a medical knowledge-sharing platform. The company provides business management services; CMO services, including pre-clinical study, clinical trial, and commercial production of antibodies and recombinant proteins; maintenance, repair, and operation; quarantine; and military logistics s...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1932
• Country: South Korea
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 000640

Financial Performance

In 2025, Dong-A Socio Holdings's revenue was 1.43 trillion, an increase of 7.24% compared to the previous year's 1.33 trillion. Earnings were 90.94 billion, an increase of 56.74%.